Premium
OVARIAN ELECTROCAUTERY VERSUS HUMAN MENOPAUSAL GONADOTROPHINS AND PURE FOLLICLE STIMULATING HORMONE THERAPY IN THE TREATMENT OF PATIENTS WITH POLYCYSTIC OVARIAN DISEASE
Author(s) -
GADIR AHMED ABDEL,
MOWAFI RAOUF S.,
ALNASER HUDA M. I.,
ALRASHID ABDULLA H.,
ALONEZI ONEZI M.,
SHAW ROBERT W.
Publication year - 1990
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.1990.tb03896.x
Subject(s) - menotropins , polycystic ovarian disease , ovulation , pregnancy rate , medicine , follicle stimulating hormone , polycystic ovary , clomifene , pregnancy , gynecology , infertility , follicle , hormone , ovulation induction , endocrinology , luteinizing hormone , biology , insulin , insulin resistance , genetics
SUMMARY Eighty‐eight clomiphene citrate‐resistant infertile patients with oligomeno‐rrhoea or amenorrhoea attributable to polycystic ovarian disease were divided at random into three groups. Twenty‐nine patients were treated with ovarian electrocautery, 30 with human menopausal gonadotropins (hMG) and 29 with pure follicle stimulating hormone (FSH). Successful ovulation was induced in 71‐4, 70‐6 and 66‐7% of the cycles in the groups respectively. Ten patients conceived after electrocautery and pure FSH therapy while 15 conceived after hMG medication (chi‐squared = 1 ‐6464, P = 0–439). The six‐cycle cumulative pregnancy rate in the three consecutive groups was 521, 55‐4 and 38‐3%. Four further pregnancies were achieved after treating 10 patients in the electrocautery group with clomiphene citrate (100 mg/day for 5 days) for 25 cycles. The rate of pregnancy wastage in the corresponding groups was 21‐4, 53‐3 and 40% (chi‐squared = 3–127, P = 0–2039). Ovarian electrocautery is equally effective as hMG and pure FSH in the treatment of PCO patients resistant to clomiphene citrate therapy.